The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transfection Technologies Market Research Report 2025
Synopsis
The global Transfection Technologies market was valued at US$ 747.4 million in 2023 and is anticipated to reach US$ 1189.5 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The use of transfection technologies is driven by several factors, including:
1. Gene expression and functional studies: Transfection technologies enable the introduction of genetic material, such as DNA or RNA, into cells, allowing researchers to study gene expression and function. By introducing specific genes or gene silencing techniques, researchers can investigate the roles of genes in cellular processes, disease mechanisms, and various biological pathways.
2. Disease modeling and drug discovery: Transfection techniques play a crucial role in disease modeling and drug discovery. They allow researchers to introduce disease-associated genetic mutations or modify gene expression in cells to study disease mechanisms, screen drug candidates, and evaluate their therapeutic potential. Transfection technologies enable the development of cellular models that closely mimic disease conditions, aiding in the discovery and development of new treatments.
3. Protein production and recombinant protein expression: Transfection techniques are utilized to produce recombinant proteins of interest in various research, pharmaceutical, and biotechnology applications. By introducing expression vectors into cells, researchers can produce large amounts of recombinant proteins for downstream analysis, functional assays, or therapeutic applications. Transfection enables the efficient production of proteins that may be difficult to obtain through other methods.
4. Genetic engineering and genome editing: Transfection technologies are fundamental to genetic engineering and genome editing approaches like CRISPR/Cas9. By delivering gene-editing tools and donor DNA into cells, researchers can modify specific genomic sequences, insert or delete genes, or perform targeted genetic modifications. Transfection facilitates the precise manipulation of the genome, allowing for the creation of genetically modified cells and organisms.
5. Cell reprogramming and stem cell research: Transfection techniques are integral to cell reprogramming and stem cell research. They enable the introduction of specific factors or regulatory elements into cells to induce reprogramming and convert differentiated cells into induced pluripotent stem cells (iPSCs). Transfection technologies are also utilized in the genetic modification and differentiation of stem cells for regenerative medicine applications and the study of developmental processes.
6. Biomedical and therapeutic applications: Transfection technologies have significant implications in biomedical and therapeutic applications. They enable the delivery of therapeutic nucleic acids, such as siRNA, miRNA, or gene therapy vectors, into targeted cells or tissues for the treatment of genetic disorders, cancer, or other diseases. Transfection plays a vital role in the development of innovative therapeutic strategies aimed at correcting gene mutations or modulating gene expression for therapeutic benefits.
Overall, the driving factors behind the use of transfection technologies include gene expression and functional studies, disease modeling and drug discovery, protein production and recombinant protein expression, genetic engineering and genome editing, cell reprogramming and stem cell research, as well as biomedical and therapeutic applications. These factors highlight the diverse applications of transfection technologies in basic research, pharmaceutical development, biotechnology, and clinical therapies, contributing to advancements in genetics, molecular biology, and medicine.
This report aims to provide a comprehensive presentation of the global market for Transfection Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transfection Technologies.
Report Scope
The Transfection Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transfection Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transfection Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Polyplus Transfection
MaxCyte
Promega Corporation
Thermo Fisher Scientific
Affymetrix
Agilent Technologies
Altogen Biosystems
Boca Scientific
Chemicell
CytoPulse
Clontech
Deliverics
GE Healthcare Life Sciences
IBA GmbH
Lonza
Inovio Pharmaceuticals
Merck KGaA
Miltenyi Biotec
Oz Biosciences
Segment by Type
Lipofection
Electroporation
Nucleofection
Others
Segment by Application
Research Centers & Academic/Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transfection Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Transfection Technologies market was valued at US$ 747.4 million in 2023 and is anticipated to reach US$ 1189.5 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The use of transfection technologies is driven by several factors, including:
1. Gene expression and functional studies: Transfection technologies enable the introduction of genetic material, such as DNA or RNA, into cells, allowing researchers to study gene expression and function. By introducing specific genes or gene silencing techniques, researchers can investigate the roles of genes in cellular processes, disease mechanisms, and various biological pathways.
2. Disease modeling and drug discovery: Transfection techniques play a crucial role in disease modeling and drug discovery. They allow researchers to introduce disease-associated genetic mutations or modify gene expression in cells to study disease mechanisms, screen drug candidates, and evaluate their therapeutic potential. Transfection technologies enable the development of cellular models that closely mimic disease conditions, aiding in the discovery and development of new treatments.
3. Protein production and recombinant protein expression: Transfection techniques are utilized to produce recombinant proteins of interest in various research, pharmaceutical, and biotechnology applications. By introducing expression vectors into cells, researchers can produce large amounts of recombinant proteins for downstream analysis, functional assays, or therapeutic applications. Transfection enables the efficient production of proteins that may be difficult to obtain through other methods.
4. Genetic engineering and genome editing: Transfection technologies are fundamental to genetic engineering and genome editing approaches like CRISPR/Cas9. By delivering gene-editing tools and donor DNA into cells, researchers can modify specific genomic sequences, insert or delete genes, or perform targeted genetic modifications. Transfection facilitates the precise manipulation of the genome, allowing for the creation of genetically modified cells and organisms.
5. Cell reprogramming and stem cell research: Transfection techniques are integral to cell reprogramming and stem cell research. They enable the introduction of specific factors or regulatory elements into cells to induce reprogramming and convert differentiated cells into induced pluripotent stem cells (iPSCs). Transfection technologies are also utilized in the genetic modification and differentiation of stem cells for regenerative medicine applications and the study of developmental processes.
6. Biomedical and therapeutic applications: Transfection technologies have significant implications in biomedical and therapeutic applications. They enable the delivery of therapeutic nucleic acids, such as siRNA, miRNA, or gene therapy vectors, into targeted cells or tissues for the treatment of genetic disorders, cancer, or other diseases. Transfection plays a vital role in the development of innovative therapeutic strategies aimed at correcting gene mutations or modulating gene expression for therapeutic benefits.
Overall, the driving factors behind the use of transfection technologies include gene expression and functional studies, disease modeling and drug discovery, protein production and recombinant protein expression, genetic engineering and genome editing, cell reprogramming and stem cell research, as well as biomedical and therapeutic applications. These factors highlight the diverse applications of transfection technologies in basic research, pharmaceutical development, biotechnology, and clinical therapies, contributing to advancements in genetics, molecular biology, and medicine.
This report aims to provide a comprehensive presentation of the global market for Transfection Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transfection Technologies.
Report Scope
The Transfection Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transfection Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transfection Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Polyplus Transfection
MaxCyte
Promega Corporation
Thermo Fisher Scientific
Affymetrix
Agilent Technologies
Altogen Biosystems
Boca Scientific
Chemicell
CytoPulse
Clontech
Deliverics
GE Healthcare Life Sciences
IBA GmbH
Lonza
Inovio Pharmaceuticals
Merck KGaA
Miltenyi Biotec
Oz Biosciences
Segment by Type
Lipofection
Electroporation
Nucleofection
Others
Segment by Application
Research Centers & Academic/Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transfection Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transfection Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lipofection
1.2.3 Electroporation
1.2.4 Nucleofection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transfection Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Centers & Academic/Government Institutes
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transfection Technologies Market Perspective (2019-2030)
2.2 Transfection Technologies Growth Trends by Region
2.2.1 Global Transfection Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transfection Technologies Historic Market Size by Region (2019-2024)
2.2.3 Transfection Technologies Forecasted Market Size by Region (2025-2030)
2.3 Transfection Technologies Market Dynamics
2.3.1 Transfection Technologies Industry Trends
2.3.2 Transfection Technologies Market Drivers
2.3.3 Transfection Technologies Market Challenges
2.3.4 Transfection Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transfection Technologies Players by Revenue
3.1.1 Global Top Transfection Technologies Players by Revenue (2019-2024)
3.1.2 Global Transfection Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Transfection Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transfection Technologies Revenue
3.4 Global Transfection Technologies Market Concentration Ratio
3.4.1 Global Transfection Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transfection Technologies Revenue in 2023
3.5 Transfection Technologies Key Players Head office and Area Served
3.6 Key Players Transfection Technologies Product Solution and Service
3.7 Date of Enter into Transfection Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transfection Technologies Breakdown Data by Type
4.1 Global Transfection Technologies Historic Market Size by Type (2019-2024)
4.2 Global Transfection Technologies Forecasted Market Size by Type (2025-2030)
5 Transfection Technologies Breakdown Data by Application
5.1 Global Transfection Technologies Historic Market Size by Application (2019-2024)
5.2 Global Transfection Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transfection Technologies Market Size (2019-2030)
6.2 North America Transfection Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transfection Technologies Market Size by Country (2019-2024)
6.4 North America Transfection Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transfection Technologies Market Size (2019-2030)
7.2 Europe Transfection Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transfection Technologies Market Size by Country (2019-2024)
7.4 Europe Transfection Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transfection Technologies Market Size (2019-2030)
8.2 Asia-Pacific Transfection Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transfection Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Transfection Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transfection Technologies Market Size (2019-2030)
9.2 Latin America Transfection Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transfection Technologies Market Size by Country (2019-2024)
9.4 Latin America Transfection Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transfection Technologies Market Size (2019-2030)
10.2 Middle East & Africa Transfection Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transfection Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Transfection Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Transfection Technologies Introduction
11.1.4 Bio-Rad Revenue in Transfection Technologies Business (2019-2024)
11.1.5 Bio-Rad Recent Development
11.2 Polyplus Transfection
11.2.1 Polyplus Transfection Company Detail
11.2.2 Polyplus Transfection Business Overview
11.2.3 Polyplus Transfection Transfection Technologies Introduction
11.2.4 Polyplus Transfection Revenue in Transfection Technologies Business (2019-2024)
11.2.5 Polyplus Transfection Recent Development
11.3 MaxCyte
11.3.1 MaxCyte Company Detail
11.3.2 MaxCyte Business Overview
11.3.3 MaxCyte Transfection Technologies Introduction
11.3.4 MaxCyte Revenue in Transfection Technologies Business (2019-2024)
11.3.5 MaxCyte Recent Development
11.4 Promega Corporation
11.4.1 Promega Corporation Company Detail
11.4.2 Promega Corporation Business Overview
11.4.3 Promega Corporation Transfection Technologies Introduction
11.4.4 Promega Corporation Revenue in Transfection Technologies Business (2019-2024)
11.4.5 Promega Corporation Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Transfection Technologies Introduction
11.5.4 Thermo Fisher Scientific Revenue in Transfection Technologies Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Affymetrix
11.6.1 Affymetrix Company Detail
11.6.2 Affymetrix Business Overview
11.6.3 Affymetrix Transfection Technologies Introduction
11.6.4 Affymetrix Revenue in Transfection Technologies Business (2019-2024)
11.6.5 Affymetrix Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Detail
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Transfection Technologies Introduction
11.7.4 Agilent Technologies Revenue in Transfection Technologies Business (2019-2024)
11.7.5 Agilent Technologies Recent Development
11.8 Altogen Biosystems
11.8.1 Altogen Biosystems Company Detail
11.8.2 Altogen Biosystems Business Overview
11.8.3 Altogen Biosystems Transfection Technologies Introduction
11.8.4 Altogen Biosystems Revenue in Transfection Technologies Business (2019-2024)
11.8.5 Altogen Biosystems Recent Development
11.9 Boca Scientific
11.9.1 Boca Scientific Company Detail
11.9.2 Boca Scientific Business Overview
11.9.3 Boca Scientific Transfection Technologies Introduction
11.9.4 Boca Scientific Revenue in Transfection Technologies Business (2019-2024)
11.9.5 Boca Scientific Recent Development
11.10 Chemicell
11.10.1 Chemicell Company Detail
11.10.2 Chemicell Business Overview
11.10.3 Chemicell Transfection Technologies Introduction
11.10.4 Chemicell Revenue in Transfection Technologies Business (2019-2024)
11.10.5 Chemicell Recent Development
11.11 CytoPulse
11.11.1 CytoPulse Company Detail
11.11.2 CytoPulse Business Overview
11.11.3 CytoPulse Transfection Technologies Introduction
11.11.4 CytoPulse Revenue in Transfection Technologies Business (2019-2024)
11.11.5 CytoPulse Recent Development
11.12 Clontech
11.12.1 Clontech Company Detail
11.12.2 Clontech Business Overview
11.12.3 Clontech Transfection Technologies Introduction
11.12.4 Clontech Revenue in Transfection Technologies Business (2019-2024)
11.12.5 Clontech Recent Development
11.13 Deliverics
11.13.1 Deliverics Company Detail
11.13.2 Deliverics Business Overview
11.13.3 Deliverics Transfection Technologies Introduction
11.13.4 Deliverics Revenue in Transfection Technologies Business (2019-2024)
11.13.5 Deliverics Recent Development
11.14 GE Healthcare Life Sciences
11.14.1 GE Healthcare Life Sciences Company Detail
11.14.2 GE Healthcare Life Sciences Business Overview
11.14.3 GE Healthcare Life Sciences Transfection Technologies Introduction
11.14.4 GE Healthcare Life Sciences Revenue in Transfection Technologies Business (2019-2024)
11.14.5 GE Healthcare Life Sciences Recent Development
11.15 IBA GmbH
11.15.1 IBA GmbH Company Detail
11.15.2 IBA GmbH Business Overview
11.15.3 IBA GmbH Transfection Technologies Introduction
11.15.4 IBA GmbH Revenue in Transfection Technologies Business (2019-2024)
11.15.5 IBA GmbH Recent Development
11.16 Lonza
11.16.1 Lonza Company Detail
11.16.2 Lonza Business Overview
11.16.3 Lonza Transfection Technologies Introduction
11.16.4 Lonza Revenue in Transfection Technologies Business (2019-2024)
11.16.5 Lonza Recent Development
11.17 Inovio Pharmaceuticals
11.17.1 Inovio Pharmaceuticals Company Detail
11.17.2 Inovio Pharmaceuticals Business Overview
11.17.3 Inovio Pharmaceuticals Transfection Technologies Introduction
11.17.4 Inovio Pharmaceuticals Revenue in Transfection Technologies Business (2019-2024)
11.17.5 Inovio Pharmaceuticals Recent Development
11.18 Merck KGaA
11.18.1 Merck KGaA Company Detail
11.18.2 Merck KGaA Business Overview
11.18.3 Merck KGaA Transfection Technologies Introduction
11.18.4 Merck KGaA Revenue in Transfection Technologies Business (2019-2024)
11.18.5 Merck KGaA Recent Development
11.19 Miltenyi Biotec
11.19.1 Miltenyi Biotec Company Detail
11.19.2 Miltenyi Biotec Business Overview
11.19.3 Miltenyi Biotec Transfection Technologies Introduction
11.19.4 Miltenyi Biotec Revenue in Transfection Technologies Business (2019-2024)
11.19.5 Miltenyi Biotec Recent Development
11.20 Oz Biosciences
11.20.1 Oz Biosciences Company Detail
11.20.2 Oz Biosciences Business Overview
11.20.3 Oz Biosciences Transfection Technologies Introduction
11.20.4 Oz Biosciences Revenue in Transfection Technologies Business (2019-2024)
11.20.5 Oz Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Transfection Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Lipofection
Table 3. Key Players of Electroporation
Table 4. Key Players of Nucleofection
Table 5. Key Players of Others
Table 6. Global Transfection Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Transfection Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Transfection Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Transfection Technologies Market Share by Region (2019-2024)
Table 10. Global Transfection Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Transfection Technologies Market Share by Region (2025-2030)
Table 12. Transfection Technologies Market Trends
Table 13. Transfection Technologies Market Drivers
Table 14. Transfection Technologies Market Challenges
Table 15. Transfection Technologies Market Restraints
Table 16. Global Transfection Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Transfection Technologies Market Share by Players (2019-2024)
Table 18. Global Top Transfection Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfection Technologies as of 2023)
Table 19. Ranking of Global Top Transfection Technologies Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Transfection Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Transfection Technologies Product Solution and Service
Table 23. Date of Enter into Transfection Technologies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transfection Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Transfection Technologies Revenue Market Share by Type (2019-2024)
Table 27. Global Transfection Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Transfection Technologies Revenue Market Share by Type (2025-2030)
Table 29. Global Transfection Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Transfection Technologies Revenue Market Share by Application (2019-2024)
Table 31. Global Transfection Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Transfection Technologies Revenue Market Share by Application (2025-2030)
Table 33. North America Transfection Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Transfection Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Transfection Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Transfection Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Transfection Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Transfection Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Transfection Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Transfection Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Transfection Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Transfection Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Transfection Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Transfection Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Transfection Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Transfection Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Transfection Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bio-Rad Company Detail
Table 49. Bio-Rad Business Overview
Table 50. Bio-Rad Transfection Technologies Product
Table 51. Bio-Rad Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 52. Bio-Rad Recent Development
Table 53. Polyplus Transfection Company Detail
Table 54. Polyplus Transfection Business Overview
Table 55. Polyplus Transfection Transfection Technologies Product
Table 56. Polyplus Transfection Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 57. Polyplus Transfection Recent Development
Table 58. MaxCyte Company Detail
Table 59. MaxCyte Business Overview
Table 60. MaxCyte Transfection Technologies Product
Table 61. MaxCyte Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 62. MaxCyte Recent Development
Table 63. Promega Corporation Company Detail
Table 64. Promega Corporation Business Overview
Table 65. Promega Corporation Transfection Technologies Product
Table 66. Promega Corporation Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 67. Promega Corporation Recent Development
Table 68. Thermo Fisher Scientific Company Detail
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Transfection Technologies Product
Table 71. Thermo Fisher Scientific Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Affymetrix Company Detail
Table 74. Affymetrix Business Overview
Table 75. Affymetrix Transfection Technologies Product
Table 76. Affymetrix Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 77. Affymetrix Recent Development
Table 78. Agilent Technologies Company Detail
Table 79. Agilent Technologies Business Overview
Table 80. Agilent Technologies Transfection Technologies Product
Table 81. Agilent Technologies Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 82. Agilent Technologies Recent Development
Table 83. Altogen Biosystems Company Detail
Table 84. Altogen Biosystems Business Overview
Table 85. Altogen Biosystems Transfection Technologies Product
Table 86. Altogen Biosystems Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 87. Altogen Biosystems Recent Development
Table 88. Boca Scientific Company Detail
Table 89. Boca Scientific Business Overview
Table 90. Boca Scientific Transfection Technologies Product
Table 91. Boca Scientific Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 92. Boca Scientific Recent Development
Table 93. Chemicell Company Detail
Table 94. Chemicell Business Overview
Table 95. Chemicell Transfection Technologies Product
Table 96. Chemicell Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 97. Chemicell Recent Development
Table 98. CytoPulse Company Detail
Table 99. CytoPulse Business Overview
Table 100. CytoPulse Transfection Technologies Product
Table 101. CytoPulse Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 102. CytoPulse Recent Development
Table 103. Clontech Company Detail
Table 104. Clontech Business Overview
Table 105. Clontech Transfection Technologies Product
Table 106. Clontech Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 107. Clontech Recent Development
Table 108. Deliverics Company Detail
Table 109. Deliverics Business Overview
Table 110. Deliverics Transfection Technologies Product
Table 111. Deliverics Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 112. Deliverics Recent Development
Table 113. GE Healthcare Life Sciences Company Detail
Table 114. GE Healthcare Life Sciences Business Overview
Table 115. GE Healthcare Life Sciences Transfection Technologies Product
Table 116. GE Healthcare Life Sciences Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 117. GE Healthcare Life Sciences Recent Development
Table 118. IBA GmbH Company Detail
Table 119. IBA GmbH Business Overview
Table 120. IBA GmbH Transfection Technologies Product
Table 121. IBA GmbH Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 122. IBA GmbH Recent Development
Table 123. Lonza Company Detail
Table 124. Lonza Business Overview
Table 125. Lonza Transfection Technologies Product
Table 126. Lonza Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 127. Lonza Recent Development
Table 128. Inovio Pharmaceuticals Company Detail
Table 129. Inovio Pharmaceuticals Business Overview
Table 130. Inovio Pharmaceuticals Transfection Technologies Product
Table 131. Inovio Pharmaceuticals Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 132. Inovio Pharmaceuticals Recent Development
Table 133. Merck KGaA Company Detail
Table 134. Merck KGaA Business Overview
Table 135. Merck KGaA Transfection Technologies Product
Table 136. Merck KGaA Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 137. Merck KGaA Recent Development
Table 138. Miltenyi Biotec Company Detail
Table 139. Miltenyi Biotec Business Overview
Table 140. Miltenyi Biotec Transfection Technologies Product
Table 141. Miltenyi Biotec Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 142. Miltenyi Biotec Recent Development
Table 143. Oz Biosciences Company Detail
Table 144. Oz Biosciences Business Overview
Table 145. Oz Biosciences Transfection Technologies Product
Table 146. Oz Biosciences Revenue in Transfection Technologies Business (2019-2024) & (US$ Million)
Table 147. Oz Biosciences Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transfection Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Transfection Technologies Market Share by Type: 2023 VS 2030
Figure 3. Lipofection Features
Figure 4. Electroporation Features
Figure 5. Nucleofection Features
Figure 6. Others Features
Figure 7. Global Transfection Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Transfection Technologies Market Share by Application: 2023 VS 2030
Figure 9. Research Centers & Academic/Government Institutes Case Studies
Figure 10. Hospitals & Clinics Case Studies
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Others Case Studies
Figure 13. Transfection Technologies Report Years Considered
Figure 14. Global Transfection Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Transfection Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Transfection Technologies Market Share by Region: 2023 VS 2030
Figure 17. Global Transfection Technologies Market Share by Players in 2023
Figure 18. Global Top Transfection Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfection Technologies as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Transfection Technologies Revenue in 2023
Figure 20. North America Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Transfection Technologies Market Share by Country (2019-2030)
Figure 22. United States Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Transfection Technologies Market Share by Country (2019-2030)
Figure 26. Germany Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Transfection Technologies Market Share by Region (2019-2030)
Figure 34. China Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Transfection Technologies Market Share by Country (2019-2030)
Figure 42. Mexico Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Transfection Technologies Market Share by Country (2019-2030)
Figure 46. Turkey Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Transfection Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bio-Rad Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 49. Polyplus Transfection Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 50. MaxCyte Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 51. Promega Corporation Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 53. Affymetrix Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 54. Agilent Technologies Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 55. Altogen Biosystems Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 56. Boca Scientific Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 57. Chemicell Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 58. CytoPulse Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 59. Clontech Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 60. Deliverics Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 61. GE Healthcare Life Sciences Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 62. IBA GmbH Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 63. Lonza Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 64. Inovio Pharmaceuticals Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 65. Merck KGaA Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 66. Miltenyi Biotec Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 67. Oz Biosciences Revenue Growth Rate in Transfection Technologies Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
